GlassScriptPhysician profile
Christine Rodgers
NPI 1437231982
$2,172.01
in general payments reported to CMS, 2019-2025
10 companies · $215 in 2025
The $215 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $442 · 2020: $125 · 2021: $149 · 2022: $120 · 2023: $121 · 2024: $999 · 2025: $215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $762 · Food and Beverage: $473 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $761.66 |
| Food and Beverage | $473.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $100.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $847.48 | 2024-2025 | Acell, Integra, Integra Dermal Regeneration Template |
| Allergan, INC. | $347.95 | 2019-2022 | |
| Abbvie INC. | $287.63 | 2023-2025 | |
| Merz North America, INC. | $224.21 | 2019-2020 | |
| Galderma Laboratories, L.P. | $206.52 | 2019-2024 | |
| Mentor Worldwide LLC | $110.79 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Axogen | $56.20 | 2025 | |
| Sientra, INC. | $45.83 | 2019-2020 | |
| Musculoskeletal Transplant Foundation INC. | $26.79 | 2025 | |
| Dilon Technologies, INC. | $18.61 | 2025 | Hemoblast Bellows |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Rodgers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.